» Articles » PMID: 19323041

Anti-tuberculosis Drug Resistance and HIV Co-infection in Phnom Penh, Cambodia

Overview
Specialty Public Health
Date 2009 Mar 28
PMID 19323041
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of this study was to observe the prevalence of drug resistance in Mycobacterium tuberculosis isolates in HIV associated tuberculosis co-infected patients in Phnom Penh City. The isolates of M. tuberculosis were collected during active laboratory-based surveillance. Of the 98 isolates studied, M. tuberculosis resistance to isoniazid was seen in 23.5%, resistance to rifampicin was seen in 16.3% and multidrug-resistance (MDR-TB) was seen in 5.1%. Our findings reveal an alarmingly high level of resistance to isoniazid and rifampicin, and confirms the need for drug susceptibility testing to guide treatment in patients with culture positive tuberculosis.

Citing Articles

Initiation, scale-up and outcomes of the Cambodian National MDR-TB programme 2006-2016: hospital and community-based treatment through an NGO-NTP partnership.

Sam S, Shapiro A, Sok T, Khann S, So R, Khem S BMJ Open Respir Res. 2018; 5(1):e000256.

PMID: 29955361 PMC: 6018896. DOI: 10.1136/bmjresp-2017-000256.


Drug-resistant tuberculosis in HIV-infected patients in a national referral hospital, Phnom Penh, Cambodia.

Walls G, Bulifon S, Breysse S, Daneth T, Bonnet M, Hurtado N Glob Health Action. 2015; 8:25964.

PMID: 25623609 PMC: 4306750. DOI: 10.3402/gha.v8.25964.


Etiologies and resistance profiles of bacterial community-acquired pneumonia in Cambodian and neighboring countries' health care settings: a systematic review (1995 to 2012).

Goyet S, Vlieghe E, Kumar V, Newell S, Moore C, Bousfield R PLoS One. 2014; 9(3):e89637.

PMID: 24626053 PMC: 3953073. DOI: 10.1371/journal.pone.0089637.


Drug Resistance among Pulmonary Tuberculosis Patients in Calabar, Nigeria.

Otu A, Umoh V, Habib A, Ameh S, Lawson L, Ansa V Pulm Med. 2013; 2013:235190.

PMID: 24078872 PMC: 3781831. DOI: 10.1155/2013/235190.


Linking surveillance with action against drug-resistant tuberculosis.

Cohen T, Manjourides J, Hedt-Gauthier B Am J Respir Crit Care Med. 2012; 186(5):399-401.

PMID: 22592806 PMC: 3443807. DOI: 10.1164/rccm.201203-0394PP.